查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1491699

切片机市场评估：依产品类型、依技术类型、依应用类型、依最终用户、依地区、机会、预测，2017-2031 年

Microtome Market Assessment, By Product Type, By Technology Type, By Application Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 225 Pages | 商品交期: 3-5个工作天内

价格

全球切片机市场规模预计将从 2023 年的 1.754 亿美元成长到 2031 年的 2.7537 亿美元，2024-2031 年预测期间复合年增长率为 5.8%。近年来，市场经历了显着成长，预计未来将保持强劲的扩张速度。

切片机是一种高度精确的工具，可将生物标本切成非常薄的碎片以供检查或研究。切片机在组织学、病理学和临床研究领域至关重要。切片机市场预计在未来几年将显着扩大。有几个因素可能会扩大市场，包括研究和开发的增加、技术进步、慢性病盛行率上升以及具有健康意识的人口总体增加。此外，业界正在推出更小、更智慧的设备，这些设备可以提供更快、更准确的医疗结果，并有助于及早发现任何疾病。

随着人们意识的增强，健康的生活方式变得越来越流行。行业领导者和医疗保健利益相关者合作，为患者提供最好的工具和诊断解决方案。公共和商业组织都在筹集资金并进行大量投资，以提供优质的解决方案。这些巨头公司在努力开发和推出新产品时采用联盟、投资和併购等策略策略。

切片机是一种专用设备，有助于组织切片，同时准确且一致，消除人为错误的可能性，并大幅提高製程的速度和效率。高通量研究机构和实验室对自动化切片机的需求尤其迫切。数位技术透过与人工智慧的整合彻底改变了切片机系统。一旦组织切片被切片，数位切片机的内建影像感测器和软体就会拍摄该切片的高解析度照片。

该报告研究了全球切片机市场，并提供了市场概述，包括依技术类型、应用程式类型、最终用户、地区和参与市场的公司概况划分的趋势。

目录

第1章 研究方法论

第2章 专案范围与定义

第3章 执行摘要

第4章 2017-2031 年全球切片机市场展望

  • 市场规模及预测
  • 依产品类型
  • 依技术类型
  • 依使用类型
  • 依最终用户
  • 依地区
  • 依公司划分的市占率 (%)，2023 年

第5章 2017-2031 年全球切片机市场展望（依地区）

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第6章 市场测绘，2023 年

第7章 宏观环境与产业结构

  • 供需分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第8章 市场动态

第9章 监理架构与创新

第10章 主要与企业状况

第11章价格分析

第12章 案例研究

第13章 主要进入者展望

  • Danaher Corporation
  • Cardinal Health
  • Diapath S.p.A.
  • Leica Biosystems
  • Sakura Finetechnical Company, Ltd.
  • MEDITE GmbH
  • SLEE medical GmbH
  • Boeckeler Instruments Inc.
  • Thermo Fisher Scientific Inc.
  • SM Scientific Instruments Pvt. Ltd.

第14章 战略建议

第15章 查询及免责声明

Product Code: MX11431

Global microtome market is projected to witness a CAGR of 5.8% during the forecast period 2024-2031F, growing from USD 175.4 million in 2023 to USD 275.37 million in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.

Microtomes are highly advanced precision-based tools involved in slicing or sectioning biological specimens into very thin slices to examine or study them. Microtomes are essential in histology, pathology, or clinical research fields. The market for microtomes is anticipated to expand significantly in the upcoming years. The market has the potential to expand due to several factors, including rising research and development, technology advancements, increased prevalence of chronic disorders, and an overall increasing population aware of its health. Additionally, the industry has seen the launch of compact and smart devices that provide faster and more precise medical findings and are helpful in the early detection of any disorders.

Healthy lifestyles are becoming more popular as people become more conscious about them. Industry giants and healthcare practitioners are collaborating to provide the best tools and diagnostic solutions for patients. Both public and commercial organizations are raising money and investing a sizable sum in providing quality solutions. These massive corporations use strategic maneuvers such as collaborations, investments, and mergers and acquisitions when they are striving to develop or introduce a new product.

For instance, the Georgetown Public Hospital Corporation (GPHC) recently announced the procurement of auto tissue processors and microtome machines, which has resulted in a substantial development in the Pathology Department. The department has revolutionized sample processing with these two technologies, cutting the turnaround time from over thirty (30) days to an astounding seven days.

Technological Advancements in Microtomes

Microtomes are special instruments that help with tissue sectioning while being accurate and consistent, eliminating the possibility of human error and greatly increasing process speed and efficiency. There is a serious need for automated microtomes, especially in high-throughput research institutions and laboratories. Digital technology has revolutionized microtome systems through its integration with AI. As the tissue sections are sliced, high-resolution photographs of the sections are captured by the imaging sensors and software which are built into digital microtomes.

In addition to giving an instant visual record of the samples, digital analysis, and 3D reconstruction made easy, it facilitates the identification of abnormalities, supports better performance of quantitative evaluations, and makes sharing of results with associates and colleagues easier. Highly specialised blade materials, such as tungsten carbide and diamond, have been used because of technological advancements, ensuring accurate and reliable sectioning. These materials have improved the quality of the sections produced, elongate the life of the blade, and decreased the frequency of blade replacements which saves both time and money.

The market for microtomes has seen the introduction of Al and ML technologies, especially in digital microtomes. Algorithms can be utilized by these systems to identify and distinguish between different tissue architectures, optimize cutting parameters, and offer automated input regarding the upkeep and replacement of blades. These features simplify the tissue sectioning procedure, minimizing the need for human intervention, and raise the microtome's overall effectiveness. Manufacturers of microtome devices are able to provide remote monitoring and diagnostics due to its introduction to the Internet of Things (IoT). It minimizes downtime and guarantees optimal instrument performance by enabling customers to monitor the performance of their microtomes in real-time, receive maintenance alerts, and access remote support services. The creation of microtomes with ergonomic designs and user-friendly interfaces is the result of technological breakthroughs. These upgrades make the instruments more user-friendly, lessen operator fatigue, and provide accessibility for a wider variety of users.

For instance, medical robotics manufacturer Clarapath, Inc. has acquired Crosscope Inc., a medical artificial intelligence (AI) software startup that creates AI-powered telepathology for medical picture information extraction and precision medicine diagnostics, to offer an end-to-end digital pathology solution. According to a Clarapath Inc. press statement, the agreement will allow Crosscope Inc.'s digital pathology platform to be layered atop Clarapath Inc.'s histology automation gear, thereby improving the calibre and effectiveness of diagnostic services for future clients.

Tissue Engineering and Regenerative Medicine

The dynamic field of tissue engineering and regenerative medicine, which is at the forefront of medical research and innovation, is crucial in driving the worldwide microtome market. To create modified tissues and apply regenerative medicine in the field of research, microtomes precision machines used for the sectioning of biological specimens are essential tools. Microtomes are used in tissue engineering to create scaffold structures from biomaterials such as donor tissues. These scaffolds are used as the starting point for the culture or seeding of cells, including stem cells.

By sectioning these scaffolds precisely and consistently, microtomes make it possible to create three-dimensional structures which closely resemble the natural tissues of the human body. These artificial tissues can be used for many different things, such as growing new organs in place of injured or unhealthy ones. Microtomes are essential in the field of regenerative medicine as they facilitate the creation of tissue slices for grafting, transplanting, and other regenerative procedures. This area of study focuses on replacing or repairing damaged or degenerated tissues by utilizing tissue engineering techniques in conjunction with the body's inherent healing powers. The creation of precise-thickness tissue grafts, which is necessary for effective transplant operations, is facilitated by microtomes.

A medical genetics business called Invitae Corp. announced full access to their PCMTM (Personalised Cancer Monitoring) platform in March 2022. The technology helps identify patients with solid tumors who have molecular residual disease (MRD). Based on previous studies, Invitae PCM detects circulating tumour DNA (ctDNA) in blood using a unique set of personalized tests based on a patient's tumor. It allows for risk stratification, treatment response assessment, and cancer recurrence identification.

Increasing Demand for Rotary Microtomes

Among different microtomes, rotary microtomes are generally considered to be superior. The dominance in the global market is fueled by several important aspects. Thin tissue slices are essential for histological and pathological investigation, and this equipment is made to prepare them precisely and effectively. The capacity of rotary microtomes to generate consistently thin and uniform sections is a prerequisite for precise microscopic examination and diagnosis, which is one of its main advantages. With hard or sensitive materials, rotary microtomes' sturdy design and mechanical stability guarantee that there is little no movement or vibration during sectioning, to produce high-quality sections. With other kinds of microtomes, including sliding or vibrating microtomes, such degree of precision is hard to accomplish.

Additionally, rotating microtomes are more adaptable, considering a wider range of specimens to diversify the research in clinical settings. The functionality of rotating microtomes has been substantially improved by technological developments. Digital control panels, programmable settings, automatic sectioning, and other technologies which enhance user ease and reproducibility of findings at standard on modern models. With the reduction of human labor and rise in productivity brought by these improvements, rotary microtomes are the standard in high-throughput laboratories. The rising need for biomedical research and histopathological diagnoses is propelling the growth of the global microtome market.

Rotary microtomes are at the forefront of this growth, which offer better performance, precision, and cutting-edge features. Their dominant position in the microtome market is backed by features that can handle the demanding standards of contemporary histology laboratories. For instance, Precisionary launched the manual rotary microtome model RF-600 which is perfect for routine tissue sectioning in histology. For a reasonable price, microtome offers steadiness and extremely precise cutting. Users receive tissue sections that are high-quality, repeatable, and embedded in paraffin wax with this model.

North America to Dominate Global Microtome Market

With the biggest market share, North America became the leading force in the worldwide microtome market. North America has one of the world's most sophisticated and advanced healthcare infrastructures. Modern hospitals, research centres, and diagnostic labs in the area mostly depend on microtomes for precise tissue sectioning in fields such as pathology, histology, and research. These facilities create a significant need for microtome technology. Chronic illnesses such as cancer, heart disease, and neurological disorders are comparatively common in North America. For instance, the Canadian Cancer Society's 2022 figures show that around 233,900 cancer cases were diagnosed in Canada in 2022. For patient care and public health, accurate diagnosis and research are essential in these fields. Microtomes are essential tools for early disease identification and characterization when preparing tissue samples for histopathological investigation. For instance, Myriad Genetics, Inc. launched studies and expansion of precise oncology solutions portfolio in 2023 at the American Society of Clinical Oncology. It shows the rising need for microtomes as they are essential in research. Such innovations and research ensure the market expansion of global microtome market.

Future Market Scenario (2024 - 2031F)

One of the main factors contributing to the anticipated growth of global microtome market is the increasing research and development in medicine and diagnostics. Given that technology is advancing, we can expect cutting-edge technology in the region. Players in the market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, Eli Lilly and Company and F. Hoffmann-La Roche Ltd. (Roche) develops drugs and diagnostics to treat major diseases. They announced on March 22, 2023, that they have partnered to support the development of Roche's Elecsys Microtomes.

Key Players Landscape and Outlook

Several companies are expanding business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed microtomes to help researchers and bring up their market presence. New product launches, agreements based on contracts, acquisitions and mergers, and investments and partnerships are a few ways to grow.

In a partnership with Creaky Joints, a leading provider of support, education, advocacy, and research for people living with arthritis and rheumatic disease, it was announced in May 2022 by United Rheumatology, a rheumatology care management organization that enables rheumatologists to advance the standard of care and to develop the Cancer Wellness Center, a digital resource designed to assist those living with cancer.

The FDA approved Myriad Genetics Inc.'s BRAC Analysis CDx histology test in March 2022 for use as a companion diagnostic to identify patients with germline BRCA-mutated (gRBCAm) HER2 negative, high-risk early-stage breast cancer may benefit from Lynparza. Myriad Genetics, Inc. is a precision medicine and genetic testing company in the United States.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Microtome Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product Type
    • 4.2.1. Microtome Instruments
      • 4.2.1.1. Rotary Microtomes
      • 4.2.1.2. Cryostat Microtomes
      • 4.2.1.3. Vibrating Microtomes
      • 4.2.1.4. Others
    • 4.2.2. Microtome Accessories
      • 4.2.2.1. Microtome Blades
      • 4.2.2.2. Others
  • 4.3. By Technology Type
    • 4.3.1. Manual Microtomes
    • 4.3.2. Semi-Automated Microtomes
    • 4.3.3. Full-Automated Microtomes
  • 4.4. By Application Type
    • 4.4.1. Disease Diagnosis
    • 4.4.2. Medical Research
  • 4.5. By End-user
    • 4.5.1. Hospital Laboratories
    • 4.5.2. Clinical Laboratories
    • 4.5.3. Others
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia-Pacific
    • 4.6.4. South America
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Microtome Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product Type
      • 5.1.2.1. Microtome Instruments
        • 5.1.2.1.1. Rotary Microtomes
        • 5.1.2.1.2. Cryostat Microtomes
        • 5.1.2.1.3. Vibrating Microtomes
        • 5.1.2.1.4. Others
      • 5.1.2.2. Microtome Accessories
        • 5.1.2.2.1. Microtome Blades
        • 5.1.2.2.2. Others
    • 5.1.3. By Technology Type
      • 5.1.3.1. Manual Microtomes
      • 5.1.3.2. Semi-Automated Microtomes
      • 5.1.3.3. Full-Automated Microtomes
    • 5.1.4. By Application Type
      • 5.1.4.1. Disease Diagnosis
      • 5.1.4.2. Medical Research
    • 5.1.5. By End-user
      • 5.1.5.1. Hospital Laboratories
      • 5.1.5.2. Clinical Laboratories
      • 5.1.5.3. Others
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
        • 5.1.6.1.1. By Value
        • 5.1.6.1.2. By Volume
      • 5.1.6.2. By Product Type
        • 5.1.6.2.1. Microtome Instruments
          • 5.1.6.2.1.1. Rotary Microtomes
          • 5.1.6.2.1.2. Cryostat Microtomes
          • 5.1.6.2.1.3. Vibrating Microtomes
          • 5.1.6.2.1.4. Others
        • 5.1.6.2.2. Microtome Accessories
          • 5.1.6.2.2.1. Microtome Blades
          • 5.1.6.2.2.2. Others
      • 5.1.6.3. By Technology Type
        • 5.1.6.3.1. Manual Microtomes
        • 5.1.6.3.2. Semi-Automated Microtomes
        • 5.1.6.3.3. Full-Automated Microtomes
      • 5.1.6.4. By Application Type
        • 5.1.6.4.1. Disease Diagnosis
        • 5.1.6.4.2. Medical Research
      • 5.1.6.5. By End-user
        • 5.1.6.5.1. Hospital Laboratories
        • 5.1.6.5.2. Clinical Laboratories
        • 5.1.6.5.3. Others
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product Type
  • 6.2. By Technology Type
  • 6.3. By Application Type
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Danaher Corporation
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Cardinal Health
  • 13.3. Diapath S.p.A.
  • 13.4. Leica Biosystems
  • 13.5. Sakura Finetechnical Company, Ltd.
  • 13.6. MEDITE GmbH
  • 13.7. SLEE medical GmbH
  • 13.8. Boeckeler Instruments Inc.
  • 13.9. Thermo Fisher Scientific Inc.
  • 13.10. SM Scientific Instruments Pvt. Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 2. Global Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 4. Global Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 5. Global Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 6. Global Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Microtome Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 9. North America Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 11. North America Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 12. North America Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 13. North America Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Microtome Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 16. United States Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 18. United States Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 19. United States Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 20. United States Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 22. Canada Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 24. Canada Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 25. Canada Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 26. Canada Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 28. Mexico Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 30. Mexico Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 31. Mexico Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 32. Mexico Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 34. Europe Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 36. Europe Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 37. Europe Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 38. Europe Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Microtome Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 41. Germany Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 43. Germany Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 44. Germany Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 45. Germany Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 47. France Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 49. France Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 50. France Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 51. France Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 53. Italy Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 55. Italy Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 56. Italy Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 57. Italy Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 59. United Kingdom Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 61. United Kingdom Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 62. United Kingdom Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 63. United Kingdom Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 65. Russia Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 67. Russia Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 68. Russia Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 69. Russia Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 71. Netherlands Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 73. Netherlands Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 74. Netherlands Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 75. Netherlands Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 77. Spain Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 79. Spain Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 80. Spain Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 81. Spain Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 83. Turkey Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 85. Turkey Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 86. Turkey Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 87. Turkey Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 89. Poland Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 91. Poland Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 92. Poland Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 93. Poland Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 95. South America Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 97. South America Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 98. South America Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 99. South America Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Microtome Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 102. Brazil Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 104. Brazil Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 105. Brazil Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 106. Brazil Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 108. Argentina Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 110. Argentina Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 111. Argentina Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 112. Argentina Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 114. Asia-Pacific Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 116. Asia-Pacific Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 117. Asia-Pacific Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 118. Asia-Pacific Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Microtome Market Share (%), By Country, 2017-2031F
  • Figure 120. India Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 121. India Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 123. India Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 124. India Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 125. India Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 127. China Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 129. China Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 130. China Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 131. China Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 133. Japan Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 135. Japan Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 136. Japan Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 137. Japan Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 139. Australia Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 141. Australia Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 142. Australia Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 143. Australia Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 145. Vietnam Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 147. Vietnam Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 148. Vietnam Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 149. Vietnam Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 151. South Korea Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 153. South Korea Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 154. South Korea Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 155. South Korea Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 157. Indonesia Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 159. Indonesia Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 160. Indonesia Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 161. Indonesia Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 163. Philippines Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 165. Philippines Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 166. Philippines Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 167. Philippines Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 169. Middle East & Africa Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 171. Middle East & Africa Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 172. Middle East & Africa Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 173. Middle East & Africa Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Microtome Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 176. Saudi Arabia Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 178. Saudi Arabia Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 179. Saudi Arabia Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 180. Saudi Arabia Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 182. UAE Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 184. UAE Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 185. UAE Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 186. UAE Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Microtome Market, By Value, In USD Million, 2017-2031F
  • Figure 188. South Africa Microtome Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa Microtome Market Share (%), By Product Type, 2017-2031F
  • Figure 190. South Africa Microtome Market Share (%), By Technology Type, 2017-2031F
  • Figure 191. South Africa Microtome Market Share (%), By Application Type, 2017-2031F
  • Figure 192. South Africa Microtome Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 194. By Technology Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 195. By Application Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023